slides
The influence of the CYP2D6*4 polymorphism on drug response and disease susceptibility
- Publication date
- 20 November 2009
- Publisher
- This thesis is about the role of CYP2D6, a drug-metabolizing enzyme, in today’s pharmacotherapy.
Cytochrome P450 2D6 (CYP2D6) is an important member of a large family of enzymes
with the name cytochrome P450 which is abundantly present in most non-monocellular living
organisms. Its history probably goes back for millions of years, when animals developed detoxifying
enzymes as a defence mechanism against plant stress metabolites. Evolutionary pressure
led to more and more diversity in these P450 genes. Nowadays, this genetic variation in
CYP2D6 plays an important role in explaining variability in drug response. In this introduction,
the variability in drug response will be discussed, followed by genetic variation, pharmacokinetics
and pharmacodynamics, the cytochrome P450 enzyme family, the possible infl uence of
CYP2D6 on drug response and adverse reactions to drugs, disease susceptibility, and aims and
scope of this thesis.